Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-03-30
1994-09-06
Higel, Floyd D.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
544105, 544331, 546121, 546159, 546168, 548139, 548184, 548185, 5483047, 5483051, 5483054, 5483057, 5483061, A61K 31505, A61K 3147, C07D23504, C07D23942, C07D40100
Patent
active
053449274
ABSTRACT:
A tetrahydrobenzimidazole derivative represented by formula (I): ##STR1## wherein Het represents a heterocyclic group which may be substituted with 1 to 3 substituents selected from the group consisting of a lower alkyl group, a lower alkenyl group, a lower alkynyl group, a cycloalkyl-lower alkyl group, an aralkyl group, a lower alkoxy group, a nitro group, a hydroxyl group, a lower alkoxycarbonyl group, and a halogen atom; and X represents a single bond or --NH-- which is bonded to the carbon atom or nitrogen atom of the heterocyclic ring, or a pharmaceutically acceptable salt thereof.
The compound of formula (I) and a salt thereof exhibits antagonism against 5-HT.sub.3 receptor.
REFERENCES:
patent: 3772315 (1973-11-01), Regel et al.
patent: 3873558 (1975-03-01), Grenda et al.
patent: 3907700 (1983-09-01), Grier
patent: 4414214 (1989-11-01), Habichi et al.
patent: 4820757 (1989-04-01), Spang et al.
patent: 5008397 (1991-04-01), Spang et al.
patent: 5149700 (1992-09-01), Ellingboe et al.
Koide Tokuo
Matsuhisa Akira
Miyata Keiji
Ohmori Jun-ya
Ohta Mitsuaki
Higel Floyd D.
Yamanouchi Pharmaceutical Co. Ltd.
LandOfFree
Tetrahydrobenzimidazole derivatives and pharmaceutical compositi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrobenzimidazole derivatives and pharmaceutical compositi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrobenzimidazole derivatives and pharmaceutical compositi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1330274